John H. Dodd

2.1k total citations
53 papers, 1.4k citations indexed

About

John H. Dodd is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, John H. Dodd has authored 53 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Organic Chemistry, 28 papers in Molecular Biology and 10 papers in Oncology. Recurrent topics in John H. Dodd's work include Melanoma and MAPK Pathways (16 papers), Synthesis and biological activity (10 papers) and Cytokine Signaling Pathways and Interactions (8 papers). John H. Dodd is often cited by papers focused on Melanoma and MAPK Pathways (16 papers), Synthesis and biological activity (10 papers) and Cytokine Signaling Pathways and Interactions (8 papers). John H. Dodd collaborates with scholars based in United States, Germany and Japan. John H. Dodd's co-authors include James R. Henry, Kenneth C. Rupert, John J. Siekierka, Steven M. Weinreb, Druie Cavender, Scott Wadsworth, Joel C. Barrish, Gilbert C. Olini, Arthur M. Doweyko and Kim W. McIntyre and has published in prestigious journals such as Journal of the American Chemical Society, The Journal of Immunology and Gastroenterology.

In The Last Decade

John H. Dodd

53 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
John H. Dodd United States	23	849	585	176	151	108	53	1.4k
Kenneth M. Lum United States	13	519 0.6×	985 1.7×	182 1.0×	279 1.8×	89 0.8×	20	1.5k
Steven E. Hall United States	20	574 0.7×	952 1.6×	139 0.8×	126 0.8×	124 1.1×	40	1.5k
William Seibel United States	22	438 0.5×	943 1.6×	97 0.6×	176 1.2×	80 0.7×	66	1.6k
Shin‐ichi Tsukamoto Japan	22	652 0.8×	765 1.3×	123 0.7×	147 1.0×	62 0.6×	71	1.6k
Renukadevi Patil United States	23	920 1.1×	640 1.1×	200 1.1×	163 1.1×	40 0.4×	48	1.7k
Nigel J. Liverton United States	24	711 0.8×	726 1.2×	103 0.6×	201 1.3×	99 0.9×	61	1.8k
John H. Hutchinson United States	26	654 0.8×	882 1.5×	279 1.6×	147 1.0×	70 0.6×	90	1.9k
Prabha N. Ibrahim United States	11	452 0.5×	1.1k 1.8×	279 1.6×	263 1.7×	276 2.6×	17	1.5k
Elisabetta Barresi Italy	24	472 0.6×	649 1.1×	84 0.5×	315 2.1×	77 0.7×	77	1.4k
John Wityak United States	24	581 0.7×	554 0.9×	77 0.4×	179 1.2×	68 0.6×	46	1.4k

Countries citing papers authored by John H. Dodd

Since Specialization

Citations

This map shows the geographic impact of John H. Dodd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John H. Dodd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John H. Dodd more than expected).

Fields of papers citing papers by John H. Dodd

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John H. Dodd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John H. Dodd. The network helps show where John H. Dodd may publish in the future.

Co-authorship network of co-authors of John H. Dodd

This figure shows the co-authorship network connecting the top 25 collaborators of John H. Dodd. A scholar is included among the top collaborators of John H. Dodd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with John H. Dodd. John H. Dodd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dodd, John H., Robert Jordan, Keith C. Barnett, et al.. (2023). A novel oral formulation of the melanocortin-1 receptor agonist PL8177 resolves inflammation in preclinical studies of inflammatory bowel disease and is gut restricted in rats, dogs, and humans. Frontiers in Immunology. 14. 1083333–1083333. 9 indexed citations

Spana, Carl, et al.. (2019). Probing the Role of Melanocortin Type 1 Receptor Agonists in Diverse Immunological Diseases. Frontiers in Pharmacology. 9. 1535–1535. 30 indexed citations

Wrobleski, Stephen T., Shuqun Lin, T. G. Murali Dhar, et al.. (2013). The identification of novel p38α isoform selective kinase inhibitors having an unprecedented p38α binding mode. Bioorganic & Medicinal Chemistry Letters. 23(14). 4120–4126. 15 indexed citations

Liu, Chunjian, James C. Lin, Christoph Gesenberg, et al.. (2013). Synthesis and evaluation of carbamoylmethylene linked prodrugs of BMS-582949, a clinical p38α inhibitor. Bioorganic & Medicinal Chemistry Letters. 23(10). 3028–3033. 8 indexed citations

Gilmore, John L., James E. Sheppeck, Jim J. Wang, et al.. (2013). Synthesis and structure–activity relationships of novel indazolyl glucocorticoid receptor partial agonists. Bioorganic & Medicinal Chemistry Letters. 23(19). 5448–5451. 9 indexed citations

Sheppeck, James E., John L. Gilmore, Hai-yun Xiao, et al.. (2013). Discovery of potent and selective nonsteroidal indazolyl amide glucocorticoid receptor agonists. Bioorganic & Medicinal Chemistry Letters. 23(19). 5442–5447. 9 indexed citations

Dyckman, Alaric J., Tianle Li, Sidney Pitt, et al.. (2011). Discovery of pyrrolo[2,1-f][1,2,4]triazine C6-ketones as potent, orally active p38α MAP kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(15). 4633–4637. 9 indexed citations

Kempson, James, Junqing Guo, Jagabandhu Das, et al.. (2009). Synthesis, initial SAR and biological evaluation of 1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-4-amine derived inhibitors of IκB kinase. Bioorganic & Medicinal Chemistry Letters. 19(10). 2646–2649. 16 indexed citations

Wrobleski, Stephen T., Shuqun Lin, John Hynes, et al.. (2008). Synthesis and SAR of new pyrrolo[2,1-f][1,2,4]triazines as potent p38α MAP kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(8). 2739–2744. 25 indexed citations

10.

Liu, Chunjian, James C. Lin, Sidney Pitt, et al.. (2008). Benzothiazole based inhibitors of p38α MAP kinase. Bioorganic & Medicinal Chemistry Letters. 18(6). 1874–1879. 47 indexed citations

11.

Das, Jagabandhu, Robert V. Moquin, Sidney Pitt, et al.. (2008). Pyrazolo-pyrimidines: A novel heterocyclic scaffold for potent and selective p38α inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(8). 2652–2657. 37 indexed citations

12.

Das, Jagabandhu, Chunjian Liu, Robert V. Moquin, et al.. (2006). Discovery and SAR of 2-amino-5-(thioaryl)thiazoles as potent and selective Itk inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(14). 3706–3712. 64 indexed citations

13.

Das, Jagabandhu, Chunjian Liu, Robert V. Moquin, et al.. (2006). Discovery and SAR of 2-amino-5-[(thiomethyl)aryl]thiazoles as potent and selective Itk inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(9). 2411–2415. 31 indexed citations

14.

Pitts, William J., Wayne Vaccaro, Tram Huynh, et al.. (2004). Identification of purine inhibitors of phosphodiesterase 7 (PDE7). Bioorganic & Medicinal Chemistry Letters. 14(11). 2955–2958. 38 indexed citations

15.

McIntyre, Kim W., Henry Shen, William J. Pitts, et al.. (2003). Phosphodiesterase 7A-Deficient Mice Have Functional T Cells. The Journal of Immunology. 171(12). 6414–6420. 79 indexed citations

16.

Rupert, Kenneth C., James R. Henry, John H. Dodd, et al.. (2003). Imidazopyrimidines, potent inhibitors of p38 MAP kinase. Bioorganic & Medicinal Chemistry Letters. 13(3). 347–350. 233 indexed citations

17.

Davis, Janet E., John H. Dodd, Crafford A. Harris, et al.. (1998). The development of novel and selective p56lck tyrosine kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 8(18). 2489–2494. 7 indexed citations

18.

Henry, James R., Kenneth C. Rupert, John H. Dodd, et al.. (1998). Potent inhibitors of the MAP kinase p38. Bioorganic & Medicinal Chemistry Letters. 8(23). 3335–3340. 34 indexed citations

19.

Ritchie, David M., Thomas Kirchner, John B. Moore, et al.. (1993). Experimental Antiasthmatic Activity of RWJ 22108: A Bronchoselective Calcium Entry Blocker. International Archives of Allergy and Immunology. 100(3). 274–282. 3 indexed citations

20.

Bruns, Robert F., James H. Fergus, Linda L. Coughenour, et al.. (1990). Structure-activity relationships for enhancement of adenosine A1 receptor binding by 2-amino-3-benzoylthiophenes.. Molecular Pharmacology. 38(6). 950–958. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact